INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
SEC FORM 4/Open-market saleVerified data

Rajasekar Sunil sold HQY

EVP Chief Prod & Strat Officer · HEALTHEQUITY, INC. · Common Stock

Side
SELL
Value
$11K
Shares
108
Price
$105.6
Executed
Aug 24, 2026
Disclosed
Oct 19, 2026
Disclosure timeline56 days from execution to publication · legal deadline 2 business days
Aug 24 executedOct 19, 2026 disclosed

HQY · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
32/ 100 · ELEVATED
Methodology →
  • Transaction type+12 / 20

    Open-market sale

  • Relative size+1 / 25

    $11K reported value · 0.2% of prior position

  • Filing timing+15 / 15

    Disclosed 40 business days after execution (deadline: 2)

  • Historical behavior+4 / 15

    2 prior trades recorded in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

    • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · HQY

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    36
    RS
    Rajasekar SunilEVP Chief Prod & Strat Officer
    HQYHEALTHEQUITY, INC.
    Open-market sale
    		SELL$1,905
    23 sh
    		Apr 22, 2026Oct 19, 2026
    traded Apr 22, 2026
    		+180dSEC FORM 4

    Evidence

    56
    RS
    Rajasekar SunilEVP Chief Prod & Strat Officer
    HQYHEALTHEQUITY, INC.
    Open-market purchase
    		BUY$2,186
    23 sh
    		Jul 8, 2026Oct 19, 2026
    traded Jul 8, 2026
    		+103dSEC FORM 4

    Evidence

    25
    RS
    Rajasekar SunilEVP Chief Prod & Strat Officer
    HQYHEALTHEQUITY, INC.
    Open-market purchase
    		BUY$9,756
    108 sh
    		Oct 15, 2026Oct 19, 2026
    traded Oct 15, 2026
    		+4dSEC FORM 4

    Evidence

    8
    FH
    Fiore Michael HenryFormer EVP, CCO
    HQYHEALTHEQUITY, INC.
    Tax withholding
    		F$185K
    2,032 sh
    		Oct 6, 2026Oct 8, 2026
    traded Oct 6, 2026
    		+2dSEC FORM 4

    Evidence

    12
    CS
    Cutler ScottDirector, President and CEO
    HQYHEALTHEQUITY, INC.
    Tax withholding
    		F$112K
    1,230 sh
    		Oct 6, 2026Oct 8, 2026
    traded Oct 6, 2026
    		+2dSEC FORM 4

    Evidence

    15
    LM
    Lucania James MEVP & CFO
    HQYHEALTHEQUITY, INC.
    Tax withholding
    		F$257K
    2,822 sh
    		Oct 6, 2026Oct 8, 2026
    traded Oct 6, 2026
    		+2dSEC FORM 4

    Evidence

    12
    LD
    Ladd DelanoEVP, General Counsel
    HQYHEALTHEQUITY, INC.
    Tax withholding
    		F$98K
    1,080 sh
    		Oct 6, 2026Oct 8, 2026
    traded Oct 6, 2026
    		+2dSEC FORM 4

    Evidence

    12
    NS
    Neeleman StephenDirector, FOUNDER AND VICE CHAIRMAN
    HQYHEALTHEQUITY, INC.
    Tax withholding
    		F$100K
    1,095 sh
    		Oct 6, 2026Oct 8, 2026
    traded Oct 6, 2026
    		+2dSEC FORM 4

    Evidence

    12
    GM
    Gathright MichaelChief Customer Officer
    HQYHEALTHEQUITY, INC.
    Tax withholding
    		F$60K
    662 sh
    		Oct 6, 2026Oct 8, 2026
    traded Oct 6, 2026
    		+2dSEC FORM 4

    Evidence

    40
    Gilbert Ray Cisneros, Jr.DSelf
    HQYHEALTHEQUITY, INC.
    Purchase
    		BUY$1,001 – $15KJul 10, 2026Sep 4, 2026
    traded Jul 10, 2026
    		+56dHOUSE PTR

    Evidence

    10
    FH
    Fiore Michael HenryEVP, CHIEF COMMERCIAL OFFICER
    HQYHEALTHEQUITY, INC.
    Open-market sale · 10b5-1 plan
    		SELL$235K
    2,470 sh
    		Jul 2, 2026Jul 7, 2026
    traded Jul 2, 2026
    		+5dSEC FORM 4

    Evidence

    25
    Gilbert Ray Cisneros, Jr.DSelf
    HQYHEALTHEQUITY, INC.
    Purchase
    		BUY$1,001 – $15KJun 30, 2026Jul 2, 2026
    traded Jun 30, 2026
    		+2dHOUSE PTR

    Evidence

    13
    WF
    Wellborn Gayle FurgursonDirector
    HQYHEALTHEQUITY, INC.
    Grant or award
    		A—
    2,877 sh
    		Jun 25, 2026Jun 29, 2026
    traded Jun 25, 2026
    		+4dSEC FORM 4

    Evidence

    21
    GW
    Gassen WilliamDirector
    HQYHEALTHEQUITY, INC.
    Grant or award
    		A—
    2,877 sh
    		Jun 25, 2026Jun 29, 2026
    traded Jun 25, 2026
    		+4dSEC FORM 4

    Evidence

    13
    PB
    Parker Stuart B.Director
    HQYHEALTHEQUITY, INC.
    Grant or award
    		A—
    2,877 sh
    		Jun 25, 2026Jun 29, 2026
    traded Jun 25, 2026
    		+4dSEC FORM 4

    Evidence

    13
    NR
    Natarajan RajeshDirector
    HQYHEALTHEQUITY, INC.
    Grant or award
    		A—
    2,877 sh
    		Jun 25, 2026Jun 29, 2026
    traded Jun 25, 2026
    		+4dSEC FORM 4

    Evidence

    17
    MC
    McCowan Debra CharlotteDirector
    HQYHEALTHEQUITY, INC.
    Grant or award
    		A—
    2,877 sh
    		Jun 25, 2026Jun 29, 2026
    traded Jun 25, 2026
    		+4dSEC FORM 4

    Evidence

    24
    Gilbert Ray Cisneros, Jr.DSelf
    HQYHEALTHEQUITY, INC.
    Purchase
    		BUY$1,001 – $15KMay 29, 2026Jun 8, 2026
    traded May 29, 2026
    		+10dHOUSE PTR

    Evidence

    15
    FH
    Fiore Michael HenryEVP, CHIEF COMMERCIAL OFFICER
    HQYHEALTHEQUITY, INC.
    Open-market sale · 10b5-1 plan
    		SELL$298K
    3,142 sh
    		May 29, 2026Jun 2, 2026
    traded May 29, 2026
    		+4dSEC FORM 4

    Evidence

    12
    LD
    Ladd DelanoEVP, General Counsel
    HQYHEALTHEQUITY, INC.
    Tax withholding
    		F$208K
    2,481 sh
    		Apr 6, 2026Apr 8, 2026
    traded Apr 6, 2026
    		+2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0001934884-26-000007
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Aug 24, 2026
    Published
    Oct 19, 2026
    Ingested by INSIDER
    Nov 5, 02:10 UTC
    Last re-read
    Nov 5, 02:10 UTC

    Extracted facts

    Filer
    Rajasekar Sunil
    Role
    EVP Chief Prod & Strat Officer
    Transaction
    Open-market saleAs filed: “S”
    Asset
    HEALTHEQUITY, INC.
    Ticker
    HQY
    Shares
    108
    Price per share
    $105.6
    Value
    $11,405
    Execution date (reported)
    Aug 24, 2026
    Owned after transaction
    53.3K shares
    Days from execution to publication
    56

    Calculation

    Value = shares × reported price per share

    • Shares: 108
    • Price: $105.6

    = $11,405

    What this establishes

    Rajasekar Sunil filed this Form 4 reporting a open-market sale of HQY on Aug 24, 2026. It became public on Oct 19, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    EVP Chief Prod & Strat Officer
    Rajasekar Sunilcik:0001934884
    Issuer
    HEALTHEQUITY, INC.cik:0001428336

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.